Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
de Pouvourville G, Armoiry X, Lavorel A, Bilbault P, Maugendre P, Bensimon L, Beziz D, Blin P, Borget I, Bouée S, Collignon C, Dervaux B, Durand-Zaleski I, Julien M, de Léotoing L, Majed L, Martelli N, Séjourné T, Viprey M. de Pouvourville G, et al. Among authors: blin p. Therapie. 2022 Nov 12:S0040-5957(22)00240-2. doi: 10.1016/j.therap.2022.11.001. Online ahead of print. Therapie. 2022. PMID: 36464522
Données et preuves en vie réelle dans l’évaluation des technologies de santé : dans quels cas sont-elles complémentaires, substitutives, ou les seules sources de données par rapport aux essais cliniques ?
de Pouvourville G, Armoiry X, Lavorel A, Bilbault P, Maugendre P, Bensimon L, Beziz D, Blin P, Borget I, Bouée S, Collignon C, Dervaux B, Durand-Zaleski I, Julien M, de Léotoing L, Majed L, Martelli N, Séjourné T, Viprey M. de Pouvourville G, et al. Among authors: blin p. Therapie. 2022 Oct 29:S0040-5957(22)00236-0. doi: 10.1016/j.therap.2022.10.067. Online ahead of print. Therapie. 2022. PMID: 36446648 French. No abstract available.
Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database.
Thurin NH, Rouyer M, Jové J, Gross-Goupil M, Haaser T, Rébillard X, Soulié M, de Pouvourville G, Capone C, Bazil ML, Messaoudi F, Lamarque S, Bignon E, Droz-Perroteau C, Moore N, Blin P. Thurin NH, et al. Among authors: blin p. Expert Rev Clin Pharmacol. 2022 Sep;15(9):1139-1145. doi: 10.1080/17512433.2022.2115356. Epub 2022 Aug 25. Expert Rev Clin Pharmacol. 2022. PMID: 35984212
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
Blin P, Dureau-Pournin C, Bénichou J, Cottin Y, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N. Blin P, et al. Am J Cardiovasc Drugs. 2022 Jan;22(1):111. doi: 10.1007/s40256-021-00517-2. Am J Cardiovasc Drugs. 2022. PMID: 34932197 No abstract available.
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.
Blin P, Darmon P, Henry P, Guiard E, Bernard MA, Dureau-Pournin C, Maizi H, Thomas-Delecourt F, Lassalle R, Droz-Perroteau C, Moore N. Blin P, et al. Cardiovasc Diabetol. 2021 Nov 25;20(1):229. doi: 10.1186/s12933-021-01416-1. Cardiovasc Diabetol. 2021. PMID: 34823531 Free PMC article.
Comparative effectiveness of dimethyl fumarate in multiple sclerosis.
Bosco-Lévy P, Debouverie M, Brochet B, Guillemin F, Louapre C, Maillart E, Heinzlef O, Lignot S, Diez P, Abouelfath A, Lassalle R, Blin P, Droz-Perroteau C. Bosco-Lévy P, et al. Among authors: blin p. Br J Clin Pharmacol. 2022 Mar;88(3):1268-1278. doi: 10.1111/bcp.15071. Epub 2021 Oct 8. Br J Clin Pharmacol. 2022. PMID: 34505304
NSAIDs and COVID-19: A Systematic Review and Meta-analysis.
Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. Moore N, et al. Among authors: blin p. Drug Saf. 2021 Sep;44(9):929-938. doi: 10.1007/s40264-021-01089-5. Epub 2021 Aug 2. Drug Saf. 2021. PMID: 34339037 Free PMC article.
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe.
Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthann S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits E, Forstner M; Intravenous Iron Consortium, Bénichou J, Bircher AJ, Garbe E, Rampton DS, Gutierrez L. Fortuny J, et al. Among authors: blin p. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1447-1457. doi: 10.1002/pds.5319. Epub 2021 Jul 12. Pharmacoepidemiol Drug Saf. 2021. PMID: 34181291 Free PMC article.
141 results